GE HealthCare Technologies Inc.
GEHC Healthcare Medical Devices
GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024. In the quarter to June 2026, revenue grew 5.75%, EPS grew 17.0%, free cash flow grew 750.0% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for three consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow GEHC
GE HealthCare Technologies Inc. (GEHC) Return on assets
GE HealthCare Technologies Inc.'s return on assets over the twelve months to 30 June 2026 was 5.45%, down 0.5 percentage points from fiscal 2025 (5.95%). Over the past ten years it has ranged from 0.00% (fiscal 2019) to 114.3% (fiscal 2020); the current reading is higher than 43% of that period. That is above the Medical Devices industry median of −19.7% and above the Healthcare sector median of −30.9%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 5.95% | (0.13) |
| FY2024 | 6.08% | 1.46 |
| FY2023 | 4.62% | (2.50) |
| FY2022 | 7.12% | (1.77) |
| FY2021 | 8.89% | (105.41) |
| FY2020 | 114.3% | 114.30 |
| FY2019 | 0.00% | — |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| DXCM DexCom, Inc. compare | 14.5% |
| PEN Penumbra, Inc. compare | 8.80% |
| BSX Boston Scientific Corporation compare | 8.47% |
| STE STERIS plc compare | 7.62% |
| EW Edwards Lifesciences Corporation compare | 7.35% |
| GEHC GE HealthCare Technologies Inc. | 5.45% |
| PHG Koninklijke Philips N.V. compare | 4.21% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 3.53% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| Medical Devices industry median | −19.7% |
| Healthcare sector median | −30.9% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on GEHC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement